Phase Ib results reported for proinsulin peptide immunotherapy in subjects with type 1 diabetes Aug. 23, 2017
JDRF enters collaboration with IBM to identify risk factors for type 1 diabetes in children Aug. 21, 2017
Hikma expands licensing agreement with Takeda for new products in the Middle East and North Africa Aug. 18, 2017
Abeona Therapeutics expands gene therapy trial for individuals with mucopolysaccharidosis type IIIA Aug. 17, 2017
RSS